Iron isomaltoside 1000
- Generic Name
- Iron isomaltoside 1000
- Drug Type
- Small Molecule
- CAS Number
- 1370654-58-2
- Unique Ingredient Identifier
- 3M6325NY1R
- Background
Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney Disease, and Anemia, Iron-Deficiency, among others.
- Associated Conditions
- Iron Deficiency (ID), Iron Deficiency Anemia (IDA)
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
- Conditions
- Peritoneal DialysisAnaemiaIron Deficiency, Anaemia
- Interventions
- First Posted Date
- 2025-03-19
- Last Posted Date
- 2025-03-19
- Lead Sponsor
- Hull University Teaching Hospitals NHS Trust
- Target Recruit Count
- 30
- Registration Number
- NCT06884280
- Locations
- 🇬🇧
Hull University Teaching Hospitals NHS Trust, Hull, East Riding Of Yorkshire, United Kingdom
Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma
- Conditions
- Nasopharyngeal CarcinomaAnemiaIron-deficiency
- Interventions
- Drug: Polysaccharide Iron Complex PillRadiation: Intensity-modulated radiotherapy
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Sun Yat-sen University
- Target Recruit Count
- 120
- Registration Number
- NCT05913414
- Locations
- 🇨🇳
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
- Conditions
- Kidney Failure, Chronic
- Interventions
- Drug: control group
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 302
- Registration Number
- NCT05719376
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.
- Conditions
- Inflammatory Bowel Diseases
- Interventions
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2022-10-14
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 152
- Registration Number
- NCT05581420
- Locations
- 🇳🇱
Leiden University Medical Centre, Leiden, Zuid-Holland, Netherlands
Single Dose Intravenous Iron Isomaltoside in Combination With Oral Iron vs Oral Iron Monotherapy in Patients With Anemia After Postpartum Haemorrhage
- Conditions
- Post Partum HemorrhageAnemia
- Interventions
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2020-08-12
- Lead Sponsor
- University of Malaya
- Target Recruit Count
- 60
- Registration Number
- NCT04505514
- Locations
- 🇲🇾
University of Malaya Medical Centre, Petaling Jaya, Wilayah Persekutuan Kuala Lumpur, Malaysia
Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).
- Conditions
- Iron-Deficiency AnemiaIron-Deficiency
- First Posted Date
- 2020-03-24
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Pierre Fabre Pharma AG
- Target Recruit Count
- 327
- Registration Number
- NCT04318405
- Locations
- 🇨🇭
8, Kreuzlingen, Switzerland
🇨🇭15, Biel, Switzerland
🇨🇭11, Kreuzlingen, Switzerland
Effect of Intravenous Iron Supplementation in Reducing Allogenic Blood Transfusion
- Conditions
- Complications
- Interventions
- Other: placebo
- First Posted Date
- 2019-08-20
- Last Posted Date
- 2020-01-22
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 80
- Registration Number
- NCT04061655
- Locations
- 🇪🇬
Ain Shams university, Cairo, Egypt
ProPBM : A Modified Patient Blood Management Protocol
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- Ministry of Health, Malaysia
- Target Recruit Count
- 180
- Registration Number
- NCT03888768
- Locations
- 🇲🇾
University Malaya Medical Centre, Jalan Universiti, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2021-05-25
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT03662789
- Locations
- 🇳🇴
Oslo university Hospital, Rikshospitalet, Oslo, Norway
Effect of IV Iron Isomaltoside on Postoperative Anemia in Total Knee Arthroplasty Patients
- First Posted Date
- 2018-03-20
- Last Posted Date
- 2019-04-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT03470649
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.